Orchestra BioMed Holdings, Inc.

OBIO

OBIOOrchestra BioMed Holdings, Inc. US flag

NASDAQ Global Market

3.91

USD

+0.08

- -

234.13MMarket Cap

Profitability (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-89.17	-61.61	-51.49	-71.21	-55.18
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	97.46	125.45	94.03	93.26	92.27	99.43
EBITDA Margin (%)	-326.41	2,764.45	-918.06	-1,855.76	-2,425.82	-153.75
Operating Margin (%)	-328.81	2,787.6	-924.34	-1,866.16	-2,437.49	-154.73
Incremental Operating Margin (%)	- -	46.99	- -	- -	- -	- -
Pretax Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-157.4
Profit Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-157.4
Net Income to Common Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-158.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	0.48
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	9	6	12	2	17	16
ST Debt	4	2	1	1	1	1
LT Debt	5	4	11	1	16	15
Total Debt/EBITDA	-0.51	-0.26	-0.37	-0.03	-0.26	-0.31
Net Debt/EBITDA	0.58	0.2	0.32	0.6	0.12	0.4
Total Debt/EBIT	-0.5	-0.26	-0.36	-0.03	-0.26	-0.31
Net Debt/EBIT	0.58	0.2	0.32	0.59	0.12	0.39
EBITDA to Interest Expense	- -	-23.32	- -	- -	- -	-44.84
EBITDA-CapEx/Interest Expense	- -	-23.62	- -	- -	- -	-45.27
EBIT to Interest Expense	- -	-23.52	- -	- -	- -	-45.13
Interest Expense	- -	1	- -	- -	- -	1
Common Equity/Total Assets	-375.7	-1,228.11	-208.99	-261.36	-406.8	-315.67
Long-Term Debt/Equity (%)	- -	- -	21.27	1.53	48.48	28.38
Long-Term Debt/Capital (%)	-4.08	-2.29	-5.95	-0.42	-5.45	-4.39
Long-Term Debt/Total Assets (%)	14.32	27.15	11.69	1.09	20.98	13.24
Total Debt/Equity (%)	-19.48	-7.96	22.59	2.48	50.15	29.78
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt/Total Assets (%)	24.82	41.94	12.42	1.77	21.7	13.89
Net Debt to Equity	22.43	5.99	-19.59	-44.91	-24.18	-38.12
Net Debt/Capital (%)	7.07	2.5	4.96	11	2.52	5.36
EBITDA	-19	-22	-32	-51	-64	-51
EBITDA-CapEx	-19	-22	-33	-51	-64	-52
Operating Income (Loss)	-19	-22	-33	-52	-64	-52

Liquidity (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.49	0.89	4.51	7.82	4.12	6.36
Current Ratio	2.52	0.92	4.56	7.95	4.27	6.45
Quick Ratio	2.5	0.9	4.52	7.82	4.13	6.37
CFO/Avg Current Liab	- -	-1.46	-1.9	-3.1	-3.69	-2.97
Common Equity/Total Assets	-375.7	-1,228.11	-208.99	-261.36	-406.8	-315.67
Long-Term Debt/Equity (%)	- -	- -	21.27	1.53	48.48	28.38
Long-Term Debt/Capital (%)	-4.08	-2.29	-5.95	-0.42	-5.45	-4.39
Long-Term Debt/Total Assets (%)	14.32	27.15	11.69	1.09	20.98	13.24
Total Debt/Equity (%)	-19.48	-7.96	22.59	2.48	50.15	29.78
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt/Total Assets (%)	24.82	41.94	12.42	1.77	21.7	13.89
CFO/Total Liabilities	-30.22	-22.92	-68.05	-169.78	-116.99	-79.89
CFO/CapEx	-48.58	-70.91	-49.56	-591.37	-174.94	-100.13
Altman's Z-Score	-3.24	-20.4	1.21	2.27	-5.57	-4.66

Working Capital (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	-5.41	32.56	28.31	27.62	358.1
Days Sales Outstanding	- -	-67.45	11.21	12.89	13.21	1.02
Inventory Turnover	- -	2.91	1.23	0.88	1.28	0.79
Days Inventory Outstanding	- -	125.64	297.54	414.06	285.38	463.93
Accounts Payable Turnover	- -	0.1	0.14	0.02	0.06	0.06
Accounts Payable Turnover Days	- -	3,505.29	2,612.06	22,382.32	6,347.21	6,266.95
Cash Conversion Cycle	- -	-3,447.1	-2,303.31	-21,955.37	-6,048.61	-5,802
Inventory to Cash Days	- -	-193.09	-286.33	-401.17	-272.17	-462.91
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	405	319	316	303	147	- -
- Cash & Cash Equivalents	20	10	20	31	22	35
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	9	6	12	2	17	16
Enterprise Value	379	313	244	217	97	-91
Total Capital	-134	-160	-188	-247	-293	-347
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt / EV	0.02	0.02	0.05	0.01	0.17	-0.18
EV/Sales	66.39	- -	68.95	78.78	36.77	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	405	319	316	303	147	- -
Diluted Enterprise Value	394	314	308	274	142	-19
EV per Share	11.98	9.91	7.71	6.54	2.63	- -
TTM Sales	6	-1	4	3	3	33
TTM EBITDA	-19	-22	-32	-51	-64	-51
TTM Operating Income	-19	-22	-33	-52	-64	-52
TTM Cash Flow to Firm	-26	-19	-29	-46	-51	-48
TTM Free Cash Flow to Firm	-26	-18	-29	-46	-50	-47

Multiples (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-15.79	-16.64	-10.99	-6.59	-2.93	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	379	313	244	217	97	-91
Low Price	10.49	9.68	9.78	4.26	3.96	2.2
EV/Sales	66.39	- -	68.95	78.78	36.77	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-16.77	-14.52	-9.33	-6.8	-3.69	- -
Price/Earnings High	-19.25	-20.14	-9.55	-15.82	-6.07	- -
Price/Earnings Low	-15.53	-13.3	-9.2	-2.88	-2.39	- -
Price/Book Value	-2.83	-1.92	-1.58	-1.22	-0.48	- -
Price/Book Value Average	-2.5	-2.01	-1.57	-1.34	-0.73	- -
Price/Book Value High	-2.87	-2.79	-1.61	-3.12	-1.2	- -
Price/Book Value Low	-2.32	-1.84	-1.55	-0.57	-0.47	- -
Price/Tangible Book Value	-8.34	-4.47	6.01	4.46	4.47	- -
Price/Tangible Book Value Average	-7.38	-4.69	5.97	4.91	6.83	- -
Price/Tangible Book Value High	-8.47	-6.51	6.11	11.42	11.24	- -
Price/Tangible Book Value Low	-6.83	-4.3	5.89	2.08	4.42	- -
Price/Sales	71.01	-407.51	89.3	109.91	55.83	- -
Price/Sales Average	62.81	-427.31	88.74	120.95	85.31	- -
Price/Sales High	72.06	-592.66	90.82	281.57	140.42	- -
Price/Sales Low	58.15	-391.34	87.51	51.28	55.27	- -
Price/Cash Flow	-15.47	-16.4	-10.77	-6.58	-2.91	- -
Price/Cash Flow Average	-13.68	-17.2	-10.7	-7.24	-4.45	- -
Price/Cash Flow High	-15.7	-23.85	-10.96	-16.85	-7.33	- -
Price/Cash Flow Low	-12.67	-15.75	-10.56	-3.07	-2.88	- -
Price/Free Cash Flow Average	-13.97	-17.44	-10.92	-7.25	-4.48	- -
Price/Free Cash Flow High	-16.03	-24.2	-11.18	-16.88	-7.37	- -
Price/Free Cash Flow Low	-12.93	-15.98	-10.77	-3.07	-2.9	- -
EV/Sales Average	60.9	- -	86.5	110.49	83.13	- -
EV/Sales High	70.16	- -	88.58	271.11	138.24	- -
EV/Sales Low	56.24	- -	85.27	40.82	53.1	- -
EV/EBITDA Average	-18.66	-15.26	-9.42	-5.95	-3.43	0.36
EV/EBITDA High	-21.49	-21.24	-9.65	-14.61	-5.7	0.36
EV/EBITDA Low	-17.23	-13.96	-9.29	-2.2	-2.19	0.36
EV/EBIT Average	-18.52	-15.13	-9.36	-5.92	-3.41	0.36
EV/EBIT High	-21.34	-21.07	-9.58	-14.53	-5.67	0.36
EV/EBIT Low	-17.1	-13.84	-9.23	-2.19	-2.18	0.36
Last Price	12.81	10.08	9.98	9.13	4	4.15
High Price	13	14.66	10.15	23.39	10.06	6.3
Enterprise Value Average	347	330	306	305	219	-19
Enterprise Value High	400	459	313	748	365	-19
Enterprise Value Low	321	302	301	113	140	-19

Profitability (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-89.17	-61.61	-51.49	-71.21	-55.18
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Gross Margin (%)	97.46	125.45	94.03	93.26	92.27	99.43
EBITDA Margin (%)	-326.41	2,764.45	-918.06	-1,855.76	-2,425.82	-153.75
Operating Margin (%)	-328.81	2,787.6	-924.34	-1,866.16	-2,437.49	-154.73
Incremental Operating Margin (%)	- -	46.99	- -	- -	- -	- -
Pretax Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-157.4
Profit Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-157.4
Net Income to Common Margin (%)	-374.45	2,942.97	-951.26	-1,779.71	-2,313.27	-158.16
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	0.48
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	9	6	12	2	17	16
ST Debt	4	2	1	1	1	1
LT Debt	5	4	11	1	16	15
Total Debt/EBITDA	-0.51	-0.26	-0.37	-0.03	-0.26	-0.31
Net Debt/EBITDA	0.58	0.2	0.32	0.6	0.12	0.4
Total Debt/EBIT	-0.5	-0.26	-0.36	-0.03	-0.26	-0.31
Net Debt/EBIT	0.58	0.2	0.32	0.59	0.12	0.39
EBITDA to Interest Expense	- -	-23.32	- -	- -	- -	-44.84
EBITDA-CapEx/Interest Expense	- -	-23.62	- -	- -	- -	-45.27
EBIT to Interest Expense	- -	-23.52	- -	- -	- -	-45.13
Interest Expense	- -	1	- -	- -	- -	1
Common Equity/Total Assets	-375.7	-1,228.11	-208.99	-261.36	-406.8	-315.67
Long-Term Debt/Equity (%)	- -	- -	21.27	1.53	48.48	28.38
Long-Term Debt/Capital (%)	-4.08	-2.29	-5.95	-0.42	-5.45	-4.39
Long-Term Debt/Total Assets (%)	14.32	27.15	11.69	1.09	20.98	13.24
Total Debt/Equity (%)	-19.48	-7.96	22.59	2.48	50.15	29.78
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt/Total Assets (%)	24.82	41.94	12.42	1.77	21.7	13.89
Net Debt to Equity	22.43	5.99	-19.59	-44.91	-24.18	-38.12
Net Debt/Capital (%)	7.07	2.5	4.96	11	2.52	5.36
EBITDA	-19	-22	-32	-51	-64	-51
EBITDA-CapEx	-19	-22	-33	-51	-64	-52
Operating Income (Loss)	-19	-22	-33	-52	-64	-52

Liquidity (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.49	0.89	4.51	7.82	4.12	6.36
Current Ratio	2.52	0.92	4.56	7.95	4.27	6.45
Quick Ratio	2.5	0.9	4.52	7.82	4.13	6.37
CFO/Avg Current Liab	- -	-1.46	-1.9	-3.1	-3.69	-2.97
Common Equity/Total Assets	-375.7	-1,228.11	-208.99	-261.36	-406.8	-315.67
Long-Term Debt/Equity (%)	- -	- -	21.27	1.53	48.48	28.38
Long-Term Debt/Capital (%)	-4.08	-2.29	-5.95	-0.42	-5.45	-4.39
Long-Term Debt/Total Assets (%)	14.32	27.15	11.69	1.09	20.98	13.24
Total Debt/Equity (%)	-19.48	-7.96	22.59	2.48	50.15	29.78
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt/Total Assets (%)	24.82	41.94	12.42	1.77	21.7	13.89
CFO/Total Liabilities	-30.22	-22.92	-68.05	-169.78	-116.99	-79.89
CFO/CapEx	-48.58	-70.91	-49.56	-591.37	-174.94	-100.13
Altman's Z-Score	-3.24	-20.4	1.21	2.27	-5.57	-4.66

Working Capital (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	-5.41	32.56	28.31	27.62	358.1
Days Sales Outstanding	- -	-67.45	11.21	12.89	13.21	1.02
Inventory Turnover	- -	2.91	1.23	0.88	1.28	0.79
Days Inventory Outstanding	- -	125.64	297.54	414.06	285.38	463.93
Accounts Payable Turnover	- -	0.1	0.14	0.02	0.06	0.06
Accounts Payable Turnover Days	- -	3,505.29	2,612.06	22,382.32	6,347.21	6,266.95
Cash Conversion Cycle	- -	-3,447.1	-2,303.31	-21,955.37	-6,048.61	-5,802
Inventory to Cash Days	- -	-193.09	-286.33	-401.17	-272.17	-462.91
Inventories	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	405	319	316	303	147	- -
- Cash & Cash Equivalents	20	10	20	31	22	35
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
+ Total Debt	9	6	12	2	17	16
Enterprise Value	379	313	244	217	97	-91
Total Capital	-134	-160	-188	-247	-293	-347
Total Debt/Capital (%)	-7.07	-3.54	-6.32	-0.68	-5.63	-4.6
Total Debt / EV	0.02	0.02	0.05	0.01	0.17	-0.18
EV/Sales	66.39	- -	68.95	78.78	36.77	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Diluted Market Cap	405	319	316	303	147	- -
Diluted Enterprise Value	394	314	308	274	142	-19
EV per Share	11.98	9.91	7.71	6.54	2.63	- -
TTM Sales	6	-1	4	3	3	33
TTM EBITDA	-19	-22	-32	-51	-64	-51
TTM Operating Income	-19	-22	-33	-52	-64	-52
TTM Cash Flow to Firm	-26	-19	-29	-46	-51	-48
TTM Free Cash Flow to Firm	-26	-18	-29	-46	-50	-47

Multiples (USD)

API Chat

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-15.79	-16.64	-10.99	-6.59	-2.93	- -
EV/EBIT	- -	- -	- -	- -	- -	- -
Enterprise Value	379	313	244	217	97	-91
Low Price	10.49	9.68	9.78	4.26	3.96	2.2
EV/Sales	66.39	- -	68.95	78.78	36.77	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-16.77	-14.52	-9.33	-6.8	-3.69	- -
Price/Earnings High	-19.25	-20.14	-9.55	-15.82	-6.07	- -
Price/Earnings Low	-15.53	-13.3	-9.2	-2.88	-2.39	- -
Price/Book Value	-2.83	-1.92	-1.58	-1.22	-0.48	- -
Price/Book Value Average	-2.5	-2.01	-1.57	-1.34	-0.73	- -
Price/Book Value High	-2.87	-2.79	-1.61	-3.12	-1.2	- -
Price/Book Value Low	-2.32	-1.84	-1.55	-0.57	-0.47	- -
Price/Tangible Book Value	-8.34	-4.47	6.01	4.46	4.47	- -
Price/Tangible Book Value Average	-7.38	-4.69	5.97	4.91	6.83	- -
Price/Tangible Book Value High	-8.47	-6.51	6.11	11.42	11.24	- -
Price/Tangible Book Value Low	-6.83	-4.3	5.89	2.08	4.42	- -
Price/Sales	71.01	-407.51	89.3	109.91	55.83	- -
Price/Sales Average	62.81	-427.31	88.74	120.95	85.31	- -
Price/Sales High	72.06	-592.66	90.82	281.57	140.42	- -
Price/Sales Low	58.15	-391.34	87.51	51.28	55.27	- -
Price/Cash Flow	-15.47	-16.4	-10.77	-6.58	-2.91	- -
Price/Cash Flow Average	-13.68	-17.2	-10.7	-7.24	-4.45	- -
Price/Cash Flow High	-15.7	-23.85	-10.96	-16.85	-7.33	- -
Price/Cash Flow Low	-12.67	-15.75	-10.56	-3.07	-2.88	- -
Price/Free Cash Flow Average	-13.97	-17.44	-10.92	-7.25	-4.48	- -
Price/Free Cash Flow High	-16.03	-24.2	-11.18	-16.88	-7.37	- -
Price/Free Cash Flow Low	-12.93	-15.98	-10.77	-3.07	-2.9	- -
EV/Sales Average	60.9	- -	86.5	110.49	83.13	- -
EV/Sales High	70.16	- -	88.58	271.11	138.24	- -
EV/Sales Low	56.24	- -	85.27	40.82	53.1	- -
EV/EBITDA Average	-18.66	-15.26	-9.42	-5.95	-3.43	0.36
EV/EBITDA High	-21.49	-21.24	-9.65	-14.61	-5.7	0.36
EV/EBITDA Low	-17.23	-13.96	-9.29	-2.2	-2.19	0.36
EV/EBIT Average	-18.52	-15.13	-9.36	-5.92	-3.41	0.36
EV/EBIT High	-21.34	-21.07	-9.58	-14.53	-5.67	0.36
EV/EBIT Low	-17.1	-13.84	-9.23	-2.19	-2.18	0.36
Last Price	12.81	10.08	9.98	9.13	4	4.15
High Price	13	14.66	10.15	23.39	10.06	6.3
Enterprise Value Average	347	330	306	305	219	-19
Enterprise Value High	400	459	313	748	365	-19
Enterprise Value Low	321	302	301	113	140	-19

	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	32	32	32	36	38	57
Diluted Weighted Avg Shares	32	32	32	33	37	- -
Basic Weighted Avg Shares	32	32	32	33	37	- -
Revenue per Share	0.18	-0.02	0.11	0.08	0.07	- -
EBITDA per Share	-0.59	-0.68	-1.03	-1.54	-1.74	- -
Operating Income per Share	-0.59	-0.69	-1.03	-1.55	-1.75	- -
Basic EPS, GAAP	-0.68	-0.73	-1.06	-1.48	-1.66	- -
Basic EPS from Cont Ops	-0.68	-0.73	-1.06	-1.48	-1.66	- -
Diluted EPS, GAAP	-0.68	-0.73	-1.06	-1.48	-1.66	- -
Diluted EPS from Cont Ops	-0.68	-0.73	-1.06	-1.48	-1.66	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.83	-0.61	-0.93	-1.39	-1.37	- -
Free Cash Flow per Basic Share	-0.85	-0.62	-0.95	-1.39	-1.38	- -
Cash & Equivalents per Share	1.13	0.34	2.65	2.64	1.81	- -
Book Value per Share	-4.53	-5.25	-6.32	-7.49	-8.42	- -
Tangible Book Value per Share	-1.54	-2.25	1.66	2.05	0.9	- -

Orchestra BioMed Holdings, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)